The trajectory of Viagra presents a complex case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, generating huge profits, the exclusivity end and the subsequent entry of generic https://pharma656494.blogripley.com/42572614/the-little-copyright-and-big-pharma-a-hazardous-investment